2.65 USD
↘ 0.11 (3.99%)AT CLOSE (03:59 PM EST)
C4 Therapeutics, Inc. (CCCC) is currently trading at $2.67. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CCCC trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Nov 16, 2026.